HopeStage
Back to all studies
CompletedNCT03222570

Adaptive Psychotherapy and Medication Strategies for Adolescent Depression

About this titleRead the official source — NCT03222570
Medication studyAges 12–18United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 12 years to 18 years.

Listed locations
MinneapolisSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 26, 2018
Recruitment status
Completed
Enrollment listed in the registry
90
Sponsor
University of Minnesota
Sponsor type
University
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention, Medication / drug, OTHER
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 12 Years to 18 Years
Official registry ID
NCT03222570
Official title
Show the full official title

An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Minneapolis

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Minnesota, a university.

Did this study involve medication?

Yes. The study involved medication, including Selective Serotonin Reuptake Inhibitor.

Who was this study for?

Listed age limits: 12 years to 18 years.

Want to explore more studies?

Explore studies